Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals

Hypertrophic Cardiomyopathy: 3 New Articles of Interest Apr 01, 2021

Hypertrophic Cardiomyopathy Center specialists have recently published three papers related to a wide range of patients with HCM, including the elderly, pediatric and general population. Dr. Milind Desai, Director of the HCM Center reviews the implications for diagnosis, management and risk stratification based on the results of these papers.

Talking Tall Rounds®: Multidisciplinary Care for the CRT Patient Mar 25, 2021

Dr. John Rickard joins Dr. Eric Roselli to discuss the cardiac resynchronization therapy – heart failure optimization clinic and key takeaways from a recent Tall Rounds® session.

Valve Disease Guidelines: Impact on Clinical Practice Mar 18, 2021

The ACC/AHA released new valve guidelines. Dr. Lars Svensson and Dr. Marc Gillinov talk about highlights addressing management of patients with valvular heart disease including TAVR (TAVI); valve surgery; timing of treatment, valve choice, valve repair, surgical approach, and how the guidelines address the aorta and the tricuspid valve.

Talking Tall Rounds®: Current State of COVID-19 & Vaccination Mar 11, 2021

Dr. Eric Roselli and Dr. Jerry Estep highlight the Heart, Vascular & Thoracic Institute's perspective on the multidisciplinary approach to COVID-19, the implications, what we've learned, and emerging treatement strategies.

Valve Disease Awareness: Clinical Update Mar 04, 2021

In honor of Valve Disease Awareness Day, valve specialists Dr. Paul Cremer and Dr. Christine Jellis answer questions they often get from clinicians referring patients for valve disease treatment. Topics include patient considerations for MitraClip, use of TMVR, TAVR for aortic regurgitation, and tricuspid valve regurgitation options. In addition the doctors discuss how anatomy, imaging and a team approach impact decision making.

Talking Tall Rounds®: Post Fontan Palliation Feb 25, 2021

Dr. Gosta Pettersson leads a discussion on Post Fontan Palliation Management Strategies.

Heart Failure Awareness: HFSA Feb 18, 2021

Heart Failure Society of America past president Randall Starling, MD, MPH sits down with current HFSA president Nancy Albert RN, PhD to talk about how HFSA started spreading the word about heart failure awarenss and the vision for 2021, moving into the future.

Talking Tall Rounds®: Cardiac ECMO in the Adult Patient Feb 11, 2021

Dr. Edward Soltesz leads a discussion on Extracorporeal membrane oxygenation (ECMO) in the adult cardiac patient.

Radiation Heart Disease - Considerations in Care Feb 04, 2021

Radiation heart disease is a difficult condition to treat. The most challenging aspect of treatment is the injury that can occur from prior radiation to all the structures of the chest. There are three phases of care. Dr. Douglas Johnston, Vice Chairman, Department of Thoracic and Cardiovascular Surgery discusses patient monitoring, imaging studies and considerations for intervention for coronary disease, valve disease, aortic disease and/or pericardial constriction.

Talking Tall Rounds®: Approaches to Left Atrial Appendage & Occlusion Jan 28, 2021

Dr. Walid Saliba provides an update on the treatment of left atrial appendage.

Pericardial Cases: Complicated Pericarditis Jan 21, 2021

Radi Zinoviev MD , Cardiology Fellow presents a case study of a young patient with Liddle’s Syndrome with long history of symptoms who presented at Cleveland Clinic for a second opinion. Dr. Zinoviev describes complicated pericarditis, the use of imaging and inflammatory markers to diagnose and guide management, and treatment strategies. Dr. Allan Klein leads a discussion following the case with Dr. Zinoviev, Dr. Christine Jellis, Dr. Alistair Phillips, Dr. Deborah Kwon and Dr. Rick Grimm.

Talking Tall Rounds®: Heart Failure with Preserved Ejection Fraction: Old Challenges, New Advances Jan 14, 2021

Dr. W.H. Wilson Tang provides an overview of novel approaches defining HFpEF and management strategies.

INOCA (Ischemia with No Obstructive Coronary Arteries) Jan 07, 2021

Patients who present with angina or even myocardial infarction may show mild or no coronary artery disease on coronary angiography. This condition, called INOCA or ischemia with no obstructive coronary arteries, is caused by microvascular dysfunction or vasospastic disorders. Dr. Khaled Ziada, a cardiologist at Cleveland Clinic specializes in this disorder and discuss how this condition is diagnosed and currently treated.

Oral Anticoagulation vs Left Atrial Appendage Closure After AF Ablation (OPTION Trial) Dec 31, 2020

Dr. Saliba and Dr. Wazni discuss the challenges of patients who would like to stop anticoagulation after atrial fibrillation ablation. The OPTION study is a research trial looking at the safety and effectiveness of the WATCHMAN device used for left atrial appendage closure vs. oral anticoagulants in patients with non valvular atrial fibrillation.

Talking Tall Rounds®: Team Based Approach to Cardio-Obstetrics Dec 24, 2020

Dr. Eric Roselli and Dr. Amit Goyal discuss cardio-obstetrics and a team based approach to patient care.

Aortic Aneurysms Dec 17, 2020

Aorta Center vascular surgeon Dr. Sean Lyden and cardiovascular medicine specialist Dr. Scott Cameron talk about information providers may find helpful, such as screening guidelines; risk factors; unusual findings during a physical exam; when patients should be referred to an aortic specialist; and treatment options from minimally invasive to open approaches

Talking Tall Rounds®: Getting to the Root of Thoracic Aneurysms Dec 10, 2020

Dr. Eric Roselli discusses thoracic aortic aneurysms, highlighting two case presentations and root replacement operative considerations.

American Heart Association 2020 Meeting Highlights Dec 03, 2020

Dr. Steve Nissen, Chief Academic Officer, Cleveland Clinic Miller Family Heart, Vascular & Thoracic Institute talks about three trials presented at the 2020 AHA Scientific Sessions: the STRENGTH trial (omega 3 fatty acid’s impact on cardiovascular events) ; STOP AF trial (medication vs. ablation in treating patients with new onset atrial fibrillation); and the RHAPSODY trial (randomized trial of rilonacept in the treatment of recurrent pericarditis). He also provides his take on the SAMSON trial (symptoms related to statins vs. placebo) and TIPS-3 (an international poly-pill study).

Talking Tall Rounds®: Rescue from Cardiac Arrest Nov 27, 2020

Dr. Eric Roselli and Dr. Amit Goyal discuss cardiac arrest and deep dive on a patient rescue.

RHAPSODY Trial Results: Recurrent Pericarditis with Rilonacept Nov 19, 2020

Dr. Allan Klein, Director of Cleveland Clinic’s Pericardial Disease Center, provides the results of the RHAPSODY trial, a pivotal Phase 3 trial that evaluated rilonacept, an interleukin 1-α and 1-β inhibitor, compared with placebo among patients with recurrent pericarditis. Study design and findings are provided, as well as implications for future care for patients with pericarditis.

Talking Tall Rounds®: Heart Transplants at the Cleveland Clinic - 2000 and Counting Nov 12, 2020

Dr. Eric Roselli and Dr. Amit Goyal discuss 2000 Heart Transplants at the Cleveland Clinic.

Robotic Surgery in Thoracic Patients Nov 05, 2020

Many thoracic surgery cases are now being performed using robotically assisted surgery. Dr. Sudish Murthy and Dr. Usman Ahmad discuss how the robot is used and the types of procedures that benefit from this minimally invasive approach.

Primary Prevention of Cardiovascular Disease for Women Oct 29, 2020

The ACC CVD in Women Committee published a summary of recommendations for primary prevention of cardiovascular disease specific to women. Dr. Leslie Cho, Director of the Women’s Cardiovascular Center and Co-Section Head, Preventive Cardiology, discusses what clinicians should know about the updated guidelines. She addresses unique risk factors that pertain to women, as well as how traditional risk factors can be different for women in presentation and treatment.

Talking Tall Rounds®: Cleveland Clinic Cardiogenic Shock Team Initiatives Oct 22, 2020

Jerry Estep, MD, Section Head of Heart Failure and Transplantation, discusses a Tall Rounds® on the topic of Cardiogenic Shock, focusing on the team approach that is required to provide optimal care. Featuring a presentation from Venu Menon MD, Section Head of Clinical Cardiology, defining cardiogenic shock and including lessons learned from the SHOCK trial and classifications of shock impact on treatment and outcomes.

State of the Art Coronary Artery Bypass Graft Surgery Oct 15, 2020

What is involved in state of the art coronary artery bypass surgery? Dr. Faisal Bakaeen, Director of the Coronary Artery Bypass Surgery Center talks about the long history of bypass surgery at Cleveland Clinic and goals for CABG surgery such as our multi-arterial strategy [including the thoracic artery, bilateral thoracic artery and use of other arteries] and the importance of surgical technique and patient selection for best outcomes. Dr. Bakaeen provides study data regarding off pump CABG and considerations to enhance quality and safety outcomes for patients undergoing CABG surgery, including high risk bypass surgery.

Talking Tall Rounds®: COVID-19 and Cardiovascular Issues Oct 08, 2020

Dr. Eric Roselli and Dr. Amit Goyal discuss COVID-19 and Early Insights into Cardiovascular Issues.

Lower Extremity PAD: Diagnosis, Medical Therapy and Revascularization Oct 01, 2020

Dr. Joseph Campbell presents his approach to peripheral artery disease. He provides a diagnostic algorithm for PAD including the limitations and strengths of various diagnostic technique; reviews medical management focused on prevention of adverse cardiac and limb related outcomes; and describes aortoiliac, femoropopliteal, popliteal and tibial interventions, providing case examples.

Talking Tall Rounds®: Digital Health and Cardiovascular Disease Management Sep 24, 2020

Dr. Eric Roselli and Dr. Amit Goyal discuss digital health and the care of the cardiovascular patient.

Heart Transplant: A Celebration of #2000 Sep 17, 2020

The Cleveland Clinic Heart, Vascular and Thoracic Institute celebrates the 2000th transplant. Cleveland Clinic began innovative work on heart transplants in 1968, with the official beginning of the program in 1984. On average, Cleveland Clinic performs 50-60 transplants per year, including between five to eight pediatric transplants per year.

Talking Tall Rounds®: Sports Cardiology and Return to Play Sep 10, 2020

Dr. Eric Roselli and Dr. Amit Goyal discuss Return to Play and Sports Cardiology.

Broken Heart Syndrome (Stress Cardiomyopathy) Sep 03, 2020

Broken Heart Syndrome, also called Stress Cardiomyopathy or Takotsubo Cardiomyopathy is a condition where patients have symptoms of a heart attack, however there is no blockage. Dr. Nissen and Dr. Kalra discuss how patients present in the emergency department, diagnostic findings, treatment, recent research findings in the time of COVID-19 and what practitioners should know about this interesting syndrome.

Talking Tall Rounds®: ECMO for Respiratory Failure Aug 27, 2020

Dr. Eric Roselli and Dr. Amit Goyal discuss respiratory ECMO therapy and management.

Hypertrophic Cardiomyopathy (HCM): Options for treatment Aug 20, 2020

Hypertrophic Cardiomyopathy (HCM) in the majority of cases causes restriction of blood flow in the outflow tract of the heart caused by systolic anterior motion (SAM) of the mitral valve. Dr. Steve Nissen talks with cardiologist Dr. Milind Desai and surgeon Dr. Nick Smedira, Directors of the Hypertrophic Cardiomyopathy Center, about current treatment options, such as medications and surgical therapy, what we have learned from years of experience with HCM at Cleveland Clinic, and a new innovative medication that is being researched that may reduce the need for – or delay surgery.

Talking Tall Rounds®: COVID-19 and Cardiovascular Issues Aug 13, 2020

Dr. Eric Roselli discusses COVID-19: Early Insights into Cardiovascular Issues.

Higher Cardiorespiratory fitness linked to better outcomes following atrial fibrillation ablation Aug 06, 2020

Level of baseline cardiopulmonary fitness strongly correlates with outcomes of atrial fibrillation ablation. Those that are more fit are more likely to maintain long term sinus rhythm, come off antiarrhythmic medications and have improved mortality. This study reinforces the impact that cardiovascular risk factors such as weight, blood pressure, diabetes, sleep apnea - and now cardiovascular fitness has on atrial fibrillation management.

Talking Tall Rounds®: Diets and Heart Health Jul 30, 2020

Dr. Eric Roselli and Dr. Amit Goyal discuss diets and heart health, cardiovascular disease prevention.

Percutaneous Coronary Interventions (PCI) for Chronic Total Occlusion (CTO) – When, Why, How Jul 23, 2020

Dr. Jay Khatri, Director of the Complex Coronary Interventions presents the definition and presentation of CTO, barriers to initiating PCI in CTO, indications for therapy and advanced skills to implement CTO PCI safely and successfully. Dr. Khatri reviews the algorithm used at Cleveland Clinic to determine CTO management.

Talking TallRounds®: COVID-19 Related Myocarditis Jul 16, 2020

Dr. Eric Roselli and Dr. Amit Goyal discuss Management of COVID-19 Related Myocarditis.

Talking TallRounds®: COVID-19 Thrombotic Complications and Hypercoagulability Jul 14, 2020

Dr. Eric Roselli and Dr. Amit Goyal discuss Thrombotic Complications and Hypercoagulability Associated with COVID-19 Infection.

COVID 19 and Athletes: Return to Play Recommendations Jul 09, 2020

What happens when an athlete has COVID-19? How does it impact the cardiovascular and cardiopulmonary fitness of the athlete? Dr. Michael Emery and Dr. Tamanna Singh, Co-Directors of the Cleveland Clinic Sports Cardiology Center, discuss the effects of COVID-19 and recommendations for return to sports. Dr. Singh and Dr. Emery highlight the expert analysis paper published by the American College of Cardiology as well as advice they provide their patients regarding return to play.

Ventricular Tachycardia: Research, Innovation and Patient Care Jul 02, 2020

Dr. Anter talks about his experience working with Dr. Mark Josephson, a pioneer in the field of electrophysiology. He describes the challenges of ventricular tachycardia ablation, particularly in the setting of heart failure, current research addressing these challenges, and his vision for ventricular tachycardia care in the future.

Primary Prevention of Cardiovascular Disease in Women Jun 25, 2020

New primary prevention guidelines for women addresses both risk factors unique to women, such as autoimmune disorders and pregnancy related factors, as well as differences in traditional risk factors such as hypertension, diabetes and hyperlipidemia. The new guidelines also covers topics that have been debated over the years such as hormone replacement therapy and aspirin.

T1b Esophageal Cancer – Should Endoscopic Resection be Considered? Jun 11, 2020

Point – Counterpoint: A lively debate covers the pros and cons involved with endoscopic vs surgical resection, followed by a summary and discussion including recent advances and research on the topic.

T1b Esophageal Cancer – Should Endoscopic Resection be Considered? Jun 04, 2020

Point – Counterpoint: A lively debate covers the pros and cons involved with endoscopic vs surgical resection, followed by a summary and discussion including recent advances and research on the topic.

Convergent Procedure for Treatment of Advanced Atrial Fibrillation May 29, 2020

The Convergent Procedure is a combination of minimally invasive surgical treatment with catheter ablation to provide the best results for patients with persistent atrial fibrillation. The recent CONVERGE trial results are discussed, followed by the highlights and considerations regarding management of patients with advanced atrial fibrillation.

Update on Lead Extraction May 21, 2020

Lead extraction requires the knowledge of three key factors that contribute to the success of this procedure. Number one is lead preparation, understanding the lead properties; second is controlled sheath advancement prior to counter traction; and last, prepare for rescue. This talk was presented at the Cleveland Clinic’s 2019 Gobal EP Summit. We look forward to Global EP Summit 2020 in September.

Ischemic VT Ablation May 14, 2020

A case presentation of a 63 yo male with history of myocardial infarction provides the setting for this talk on scar related ventricular tachycardia. Discussion includes the mechanism behind this arrhythmia, the role of ICD along with ablation, timing of VT ablation, and innovative strategies in both imaging and ablation to improve outcomes. This talk was presented at the Cleveland Clinic’s 2019 Gobal EP Summit. We look forward to Global EP Summit 2020 in September.

High Risk Coronary Intervention May 07, 2020

Dr. Steven Nissen talks with Dr. Jaikirshan Khatri about high risk coronary intervention. This includes complex patients at high risk for coronary artery bypass surgery, including those with left main coronary disease, those with chronic total occlusions, and those requiring supported percutaneous interventions. Dr. Khatri discusses imaging and newer advanced techniques which has made interventional procedures possible in these patients; and short and long term outcomes.

It’s Not just HOW You Do but WHEN You Do an Ablation Apr 30, 2020

Atrial fibrillation is a progressive disease that changes over time. It requires different goals of therapy, ablation strategies, and timing of ablation for the best outcomes. This talk was presented at the Cleveland Clinic’s 2019 Gobal EP Summit. We look forward to Global EP Summit 2020 in September. Speaker: Ayman Hussein, MD, staff cardiologist, Electrophysiology & Pacing

Advances in Cardiac Critical Care Apr 23, 2020

Dr. Venu Menon, Section Head of Clinical Cardiology and Director of the Cardiac Intensive Care Unit (CICU) at Cleveland Clinic talks with Dr. Paul Cremer and Dr. Penelope Rampersad about Advances in Cardiac Critical Care. Beginning with a historical look at CCU care, Dr. Menon reflects on the changes in critical care over the years. This is followed by a discussion of what CCU care means today, how training has changed, research and quality outcomes, and the role of palliative care in the CCU.

Advanced Pacing: Leadless, His bundle and more Apr 16, 2020

Innovations in cardiac pacing, including new strategies and emerging data, presented within the context of an interesting case presentation. Topics covered include pacing induced cardiomyopathy, pace mapping, His bundle vs. RV pacing, selective vs. non-selective HBP, CRT and leadless pacing. This talk was presented at the Cleveland Clinic’s 2019 Gobal EP Summit. We look forward to Global EP Summit 2020 in September Speaker: Daniel J Cantillon, MD, Associate Section Head & Research Director, Electrophysiology & Pacing.

CCTGA: Have we collected the needed data? Apr 09, 2020

Dr. Tara Karamlou, pediatric heart surgeon, Department of Pediatric and Congenital Heart Surgery and Cardiovascular Surgery Department and Dr. Eugene Blackstone, head of Clinical Investigations at the Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute at Cleveland Clinic provides data and research opportunities to help answer the list of questions that participants asked during the Cleveland Clinic’s 4th Annual Advances in Pediatric and Congenital Heart Summit focused on Congenitally Corrected Transposition of the Great Arteries. We look forward to the 5th Annual Advances in Congenital Heart Disease at Cleveland Clinic in October of 2020.

Innovative Cath Interventions in the Cyanotic Baby Apr 02, 2020

Dr. Thomas Fagan, interventional cardiologist in the Department of Pediatric Cardiology at Cleveland Clinic, discusses interventional options, such as PDA and RVOT shunt placements, as alternatives to surgery. The talk was presented at the Cleveland Clinic’s 4th Annual Advances in Pediatric and Congenital Heart Summit focused on Congenitally Corrected Transposition of the Great Arteries. We look forward to the 5th Annual Advances in Congenital Heart Disease at Cleveland Clinic in October of 2020.

COVID-19 and Your Heart Mar 31, 2020

Dr. Lars Svensson talks with cardiologist Dr. Kapadia and heart surgeon Dr. Gillinov about COVID-19, how it is impacting cardiac care and procedures at Cleveland Clinic and what patients should know when seeking care during this time.

CCTGA: When is it Feasible to Septate Mar 26, 2020

Dr. Hani Najm, Chairman of Pediatric and Congenital Heart Surgery, at Cleveland Clinic, discusses septation in Congenitally Corrected Transposition of the Great Arteries, including perceived contraindications to septation and the best approach to address these complex anomalies. The talk was presented at the Cleveland Clinic’s 4th Annual Advances in Pediatric and Congenital Heart Summit focused on Congenitally Corrected Transposition of the Great Arteries. We look forward to the 5th Annual Advances in Congenital Heart Disease at Cleveland Clinic in October of 2020.

VAD for the Failing Right Ventricle in CCTGA Mar 19, 2020

Dr. Alistair Phillips, pediatric heart surgeon, Department of Pediatric and Congenital Heart Surgery at Cleveland Clinic, presents considerations in use of ventricular assist devices in patients with Congenitally Corrected Transposition of the Great Arteries. The talk was presented at the Cleveland Clinic’s 4th Annual Advances in Pediatric and Congenital Heart Summit focused on Congenitally Corrected Transposition of the Great Arteries. We look forward to the 5th Annual Advances in Congenital Heart Disease at Cleveland Clinic in October of 2020.

Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death Mar 12, 2020

Dr. Tess Saarel, Chairman of Pediatric Cardiology at Cleveland Clinic, discusses ventricular arrhythmias and the prevention of sudden cardiac death in children, including guideline changes, prevention of sudden cardiac death in hypertrophic cardiomyopathy patients, challenges of placing ICDs in young patients, and the use of subcutaneous ICDs. The talk was presented at the Cleveland Clinic’s 4th Annual Advances in Pediatric and Congenital Heart Summit focused on Congenitally Corrected Transposition of the Great Arteries. We look forward to the 5th Annual Advances in Congenital Heart Disease at Cleveland Clinic in October of 2020.

New Innovations for Tricuspid Valve Disease Mar 05, 2020

Samir Kapadia, MD, Chairman, Department of Cardiovascular Medicine and Amar Krishnaswamy MD, Section Head, Interventional Cardiology discuss the nuances of tricuspid valve management for healthcare providers; including the challenges of tricuspid regurgitation; optimal medical management (other valve disease, heart failure and atrial fibrillation); the role of cardiac devices in tricuspid regurgitation; and new innovations and studies involving tricuspid valve treatment. Dr. Kapadia and Dr.Krishnaswamy discuss the focus of current trials and outcome measurements, and point out important considerations in the treatment of tricuspid regurgitation

Vascular Imaging Feb 27, 2020

Dr. Lee Kirksey, Vascular Surgeon and Vice Chairman of Vascular Surgery talks with staff vascular surgeon Dr. David Hardy , vascular medicine specialist and director of the vascular lab, Dr. Natalia Fendrikova Mahlay and imaging/diagnostic radiology specialist Dr.Paul Schoenhagen about vascular imaging. They discuss types of services that are offered in a vascular imaging lab, how cardiovascular CT and MRI work with clinicians to help diagnose conditions and plan treatment, the integration of imaging systems allowing both health system hospitals and external hospitals to share images easily, quality initiatives, as well as imaging considerations in special populations such as aortic disease and chronic kidney disease.

ISCHEMIA Trial – Will this change clinical practice? Feb 20, 2020

Dr. Stephen Ellis, Interventional Cardiologist at Cleveland Clinic takes us through the results of the International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA Trial) and provides key take-aways from the results.

Vascular Surgery: Mesenteric Ischemia Feb 13, 2020

Dr. Lee Kirksey, Vascular Surgeon and Vice Chairman of Vascular Surgery talks with staff vascular surgeons Dr. David Hardy and Dr. Francis Caputo about mesenteric ischemia, also called intestinal ischemic syndrome.

Women and Heart Disease for Healthcare Providers Feb 06, 2020

Dr. Leslie Cho,Director of the Women’s Cardiovascular Center and Co-Section Head, Preventive Cardiology discusses risk factors that clinicians can look for in women to prevent future heart disease (such as pregnancy associated cardiovascular risk factors, premature menopause, polycystic ovary syndrome, and autoimmune disease). Dr. Cho discusses research based and guideline directed strategies to initiate in patients with these risk factors.

The Gut Microbiome and Cardiovascular Disease Jan 30, 2020

Dr. Steven Nissen, Chief Academic Officer, Chief Academic Officer, Sydell and Arnold Miller Family Heart & Vascular talks with Dr. Stan Hazen, Co-Section Head, Preventive Cardiology and researcher about the gut microbiome and how it relates to cardiovascular disease. Dr. Hazen provides a description of TMAO and how it is related to diet and risk of heart and vascular disease. He describes what specific bacteria is involved with this type of activity, how they are approaching future research and treatment of cardiovascular risk gut microbiome and why the Mediterranean diet may be so effective in preventing heart disease.

Healthcare Disparity – A physician and patient perspective Jan 23, 2020

Dr. Lee Kirksey, Vascular Surgeon and Vice Chairman of Vascular Surgery is joined by Dr. Umesh Khot, Section Head Section Head, Regional Cardiology and Director of Quality in the Heart and Vascular Institute and patient Herb Pleasant to talk about health care disparities. Together they cover issues related to minority and lower socio-economic disparities and the need to develop trust in the health care system to initiate care. It is important to identify risk factors earlier in life, establish a diagnosis and treatment plan, and find a doctor who is willing to work together with the patient to adjust together. Herb also talks about the role of family in health care decisions and motivation. This presentation provides insight into both the patient and physician perspectives.

Treatment of Venous Occlusion in Thoracic Outlet Syndrome Jan 16, 2020

Dr. Lee Kirksey, Vascular Surgeon and Vice Chairman of Vascular Surgery talks with Dr. David Hardy, Department of Vascular Surgery about thoracic outlet syndrome (TOS). This condition often occurs in athletes. The physicians discuss the need for quick treatment; diagnostic testing; treatment of venous occlusion in thoracic outlet syndrome including thrombolysis, thrombectomy and/or rib resection; and recovery including protocols to get back to an active lifestyle.

3D Printing in Cardiovascular Care Jan 09, 2020

Dr. Steven Nissen, Chief Academic Officer, Sydell and Arnold Miller Family Heart & Vascular Institute talks with Dr. Serg Harb, a staff imaging cardiologist about the innovative diagnostic tool of 3D Printing – What are the clinical uses? Limitations? Research findings and future innovation.

Cardiovascular Outcomes of Bariatric (Metabolic) Surgery Jan 02, 2020

Dr. Steven Nissen, Chief Academic Officer, Chief Academic Officer, Sydell and Arnold Miller Family Heart & Vascular Institute discusses the benefits of metabolic (also called bariatric) surgery with surgeon Ali Aminian from the Bariatric and Metabolic Institute. Dr. Aminian recently published a paper in JAMA on the long term cardiovascular outcomes of metabolic surgery on patients with type 2 diabetes and obesity. Dr. Aminian describes the study, primary outcomes (all-cause mortality, coronary artery events, cerebrovascular events, heart failure, nephropathy, and atrial fibrillation), results of this study, and what this means for future care of patients. Dr. Aminian also reviews who is a candidate for this type of surgery, types of bariatric surgery, risks and benefits of surgery, and factors leading to lifelong success.

AHA 2019: Highlights with Dr. Nissen Dec 19, 2019

Dr. Steven Nissen, Chief Academic Officer, Chief Academic Officer, Sydell and Arnold Miller Family Heart & Vascular Institute discusses the benefits of metabolic (also called bariatric) surgery with surgeon Ali Aminian from the Bariatric and Metabolic Institute. Dr. Aminian recently published a paper in JAMA on the long term cardiovascular outcomes of metabolic surgery on patients with type 2 diabetes and obesity. Dr. Aminian describes the study, primary outcomes (all-cause mortality, coronary artery events, cerebrovascular events, heart failure, nephropathy, and atrial fibrillation), results of this study, and what this means for future care of patients. Dr. Aminian also reviews who is a candidate for this type of surgery, types of bariatric surgery, risks and benefits of surgery, and factors leading to lifelong success.

Drug Recalls – what you should know for patient care Dec 12, 2019

Dr. Steven Nissen, Chief Academic Officer, Chief Academic Officer, Sydell and Arnold Miller Family Heart & Vascular Institute talks with Dr. Jerry Estep, Section Head of the George M. and Linda H. Kaufman Center for Heart Failure Treatment and Recovery and Brad Williams Pharm D, pharmacy specialist for heart failure about drug recalls. In light of the recent ARB recalls, these three medical experts discuss the ARB recall, how to keep current with new recalls, what physicians should do when a medication has been recalled, the challenges of generic medications, alternative medications for heart failure and hypertension, and when ARBs should be used.

Women in Medicine Dec 05, 2019

Cardiologist Christine Jellis, MD and Cardiothoracic Surgeon, Tara Karamlou, MD talk about women in medicine – the challenges of being a woman in the field of cardiothoracic surgery and cardiovascular medicine, The Women in Thoracic Surgery (WTS) group which mentors and supports women thoracic surgeons, the advantages of being a woman in medicine, advice for young women seeking careers in medicine , including the yes-no button, importance of mentors, and having you time. This is about women in medicine but has helpful advice for all women in professional careers.

Resistant Hypertension and Cardiac Rehabilitation Nov 28, 2019

Luke Laffin, MD, Medical Director of Cardiac Rehabilitation and cardiologist in the Section of Preventive Cardiology at Cleveland Clinic talks about two related abstracts recently presented at the American Heart Association’s Hypertension Scientific Sessions focused on resistant hypertension in a cardiac rehabilitation program. Dr. Laffin defines resistant hypertension, the prevalence of resistant hypertension in a cardiac rehabilitation setting, factors associated with patients who have resistant hypertension, and lessons learned about this patient population.

Vascular Surgery: Impact of national trends on surgeon training Nov 21, 2019

Dr. Lee Kirksey, Vascular Surgeon and Vice Chairman of Vascular Surgery and Dr. Sean Lyden, MD, Chairman, Department of Vascular Surgery at Cleveland Clinic’s Sydell and Arnold Miller Family Heart & Vascular Institute discuss the changes in operative strategies for aortic aneurysm repair. As the national trend shows an increase in EVAR and decline in open repair, is it time to review current training programs to see if there is a need for specialized training in complex open aortic repair in high volume centers?

Effect of Left Ventricular Conduction Delay on Cardiovascular Mortality Nov 14, 2019

Dr. Daniel Cantillon discusses their analysis of ECG recordings of over 24,000 patients from the PRECISION study. They found that left bundle branch block (LBBB) and left intraventricular conduction defect (LIVCD) is an important risk factor for increased mortality in patients at risk for cardiovascular disease.

Association Between Transcatheter Aortic Valve Replacement and Early Postprocedural Stroke Nov 07, 2019

Dr. Venu Menon, Director of the Cardiovascular Fellowship Program and Section Head, Clinical Cardiology and Chetan Huded MD, Interventional Fellow discuss incidence of stroke up to 30 days after TAVR. Dr. Huded published his findings in JAMA . Drs. Menon and Huded discuss the patient population, pulled from the TVT registry and what the findings mean for clinical practice.

Left atrial appendage closure device implantation in patients with prior intracranial hemorrhage Oct 31, 2019

Dr. Venu Menon, Director of the Cardiovascular Fellowship Program and Section Head, Clinical Cardiology discusses with Erika Hutt, MD a first year cardiovascular fellow the use of the WATCHMAN, a left atrial appendage closure device, in patients with prior intracranial hemorrhage. Her study was recently published in Heart Rhythm. Drs. Menon and Hutt talk about the study, the patient population as well as the findings and what this means for this patient population in the future.

Mediastinal Radiation Associated Aortic Stenosis – Aortic Valve Replacement SAVR and TAVR Oct 24, 2019

Dr. Venu Menon, Director of the Cardiovascular Fellowship Program and Section Head, Clinical Cardiology talks with Eoin Donnellen MD, a third year cardiovascular fellow about the impact of radiation induced aortic stenosis on treatment. Dr. Donnellen first describes a paper looking at Aortic Valve Replacement in patients who had had mediastinal radiation vs. those who did not have radiation . His second study looked at outcomes of TAVR in patients with mediastinal radiation associated aortic stenosis. Drs. Menon and Donnellen discuss the findings of both studies and the clinical implications

Association between bariatric surgery and atrial fibrillation recurrence after ablation Oct 17, 2019

Dr. Venu Menon, Director of the Cardiovascular Fellowship Program and Section Head, Clinical Cardiology talks with Eoin Donnellen MD, a third year cardiovascular fellow about his recently published paper that looked at pre-ablation bariatric surgery and its impact on the recurrence of atrial fibrillation following atrial fibrillation ablation.

Radiation Associated Cardiac Disease Oct 10, 2019

Cardiologist Dr. Milind Desai and surgeon Dr. Doug Johnston, both experts in radiation heart disease discuss a paper that was recently published entitled, “Prevention, Diagnosis, and Management of Radiation-Associated Cardiac Disease.” This expert panel highlights the unique aspects of radiation heart disease and the importance of individualizing care. The paper includes recommendations for diagnostic testing to plan treatment and the various treatment options available. Patients and their physicians need to gather a complete profile, set realistic expectations and plan an individualized treatment plan. An experienced radiation heart disease team is required to make the best decision for this patient population to achieve best outcomes.

Cholesterol Update: LDL and Lp (a) Sep 26, 2019

Dr. Steven Nissen, Chief Academic Officer, Sydell and Arnold Miller Family Heart & Vascular Institute talks with Dr. Leslie Cho, Section Head Preventive Cardiology & Rehabilitation about LDL cholesterol and statin intolerance. They discuss the full range of options available and what is in the future for LDL management. Then, Dr. Nissen describes the latest Lipoprotein a (also called Lp (a)) – what it is, why it’s important and a new research trial addressing this new frontier in lipid management.

Vascular Surgery – Dialysis Access Expert Panel Sep 19, 2019

Dr. Lee Kirksey, Vascular Surgeon and Vice Chairman of Vascular Surgery talks with Dr. David Hardy, Department of Vascular Surgery and Dr. Tushar Vachharajany, Nephrology and Hypertension about the challenges of dialysis access. Topics include vascular access at Cleveland Clinic, what should go into the planning and implementation of vascular access, approaches to decrease catheter exposure, graft types, the multidisciplinary care of dialysis patients, many who have cardiovascular and kidney disease, challenges of management and care of patients who have urgent needs.

Endocarditis - Clinical Insights Sep 12, 2019

Dr. Gosta Pettersson, cardiac surgeon and Director of the Endocarditis Center leads a discussion with infectious disease specialist Dr. Nabin Shrestha and cardiologist Dr. Paul Cremer about endocarditis (SBE). Topics include early recognition and diagnosis, nuances and timing related to specific micro-organisms and underlying medical conditions, causes of endocarditis, counseling patients with heart valve disease, complications, morbidity and mortality related to endocarditis, indications for heart surgery and considerations for SBE treatment.

Opioid Crisis: Jerome Adams, M.D., MPH, Surgeon General of the United States Sep 05, 2019

Jerome Adams, M.D., MPH, Surgeon General of the United States and Cleveland City Council Member Blaine Griffin joined five leading Cleveland Clinic physicians to discuss the opioid epidemic during the Sydell and Arnold Miller Family Heart & Vascular Institute Grand Rounds.

Cardiomyopathy Update - Genetics and Medical Care Aug 29, 2019

Dr. Steven Nissen, Chief Academic Officer, Chief Academic Officer, Sydell and Arnold Miller Family Heart & Vascular Institute talks about cardiomyopathy with Wilson Tang, MD, Director of Cleveland Clinic’s Center for Clinical Genomics; Research Director, and staff cardiologist in the Section of Heart Failure and Cardiac Transplantation Medicine – from the basics to the newest innovations. Types of cardiomyopathy, how genetic testing can play a role in clinical management of the patient with cardiomyopathy, and the latest drugs and new research are discussed.

Structural Heart Disease Interventions – beyond TAVR Aug 22, 2019

Dr. Steven Nissen, Chief Academic Officer, Sydell and Arnold Miller Family Heart & Vascular Institute talks with Dr. Amar Krishnaswamy interventionalist and expert in structural heart disease about procedures used to treat structural heart disease, such as MitraClip, paravalvular leak repair, PFO closure, and - we all know about transcather aortic valve replacement (TAVR), but what about transcatheter mitral valve replacement (TMVR), tricuspid and pulmonic valves? Dr. Krishnaswamy describes the procedure, indications and outcomes.

Chronic Coronary Total Occlusion Aug 15, 2019

Dr. Steven Nissen, Chief Academic Officer, Chief Academic Officer, Sydell and Arnold Miller Family Heart & Vascular Institute discusses the latest techniques in treatment of total coronary total occlusion (CTO) with Dr. Jaikirshan(Jay) Khatri, specialist in CTO care. Dr. Khatri reviews patient selection – who would benefit most from this treatment, including diagnostic testing, clinical and diagnostic criteria; describes interventional techniques such as use of retrograde collaterals and advanced antegrade techniques and how stents are used during these procedures; reviews outcomes and risks of interventional procedures for chronic coronary occlusion; and discusses current research .

Bicuspid Aortic Valve – Strategies for Surgical Management Aug 08, 2019

Dr. Lars Svensson, Chairman of the Heart and Vascular Institute sits down with Dr. Doug Johnston, Surgical Director of the Aortic Valve Center to discuss considerations in the treatment of patients with bicuspid aortic valve disease, including indications for surgery for patients with aortic stenosis vs. regurgitation; diagnostic testing; how surgical approach is determined in isolated bicuspid aortic valve disease as well as combined aorta, aortic valve operations; and a patient centered approach to valve choice.

Heart Rhythm Society 2019 - Highlights Aug 01, 2019

Dr. Oussama Wazni, Section Head, Electrophysiology and Pacing at Cleveland Clinic and Dr. Dan Cantillon, Director of Research in Electrophysiology and Pacing discuss the highlights from the recent Heart Rhythm Society Meeting. Research discussed includes bariatric surgery and afib ablation; digital health in electrophysiology; central monitoring unit outcomes; HIS bundle CRT pacing and pulse field ablation.

Vascular Surgery – Quality and Affiliate Program Expert Panel Jul 25, 2019

Dr. Lee Kirksey, Vascular Surgeon and Vice Chairman of Vascular Surgery discusses the Heart & Vascular Institute Affiliate program with Dr. Suma Thomas, Vice Chairman of Operations and Strategy in the Heart & Vascular Institute and Dr. Christopher Smolock, vascular surgeon and Chief Quality Officer in the Department of Vascular Surgery. Topics include the objectives and breadth of the Affiliate program, measurements of quality and outcomes in the Department of Vascular Surgery, and how the Affiliate program is used to improve quality, patient care, research and education in affiliated hospitals. Dr. Smolock shares the experience of our open aortic program as well as initiatives to improve quality in the Vascular Surgery Department.

Pulmonary Hypertension: What clinicians should know – panel of experts Jul 18, 2019

Dr. Miriam Jacob discusses pulmonary hypertension with cardiac surgeon Dr. Michael Tong and pulmonologist Dr. Gustavo Heresi. Many topics are discussed including the complexity of evaluation and diagnosis, a review of the World Symposium on Pulmonary Hypertension recommendations and what this means for diagnosis thresholds, approaches to medical therapy, surgery for those who have chronic thromboembolic pulmonary hypertension (CTEPH), balloon pulmonary angioplasty (BPA), and when lung transplant is considered. The pulmonary hypertension team approach at Cleveland Clinic is described as well as current research studies.

Should A Patent Foramen Ovale (PFO) Be Closed in an Adult? Jul 11, 2019

Dr. Amar Krishnaswamy, MD, FACC, Interventional Cardiologist at Cleveland Clinic describes factors that play a role in deciding if an adult patient should have a PFO closure, and considerations when deciding whether PFO closure is the right course of action.

Valve Disease: When is the right time to intervene? Jul 04, 2019

Steven Nissen, MD, sits down with Marc Gillinov, MD, Chairman of the Department of Thoracic and Cardiovascular Surgery and Brian Griffin, MD, Section Head Cardiovascular Imaging to discuss the timing of heart surgery, one valve at a time – the differences between aortic and mitral valves and regurgitation and stenosis. Changes in diagnostic imaging techniques, surgical and interventional options, as well as looking at outcomes data have changed the way we look at these patients and timing of intervention.

Chronic thromboembolic pulmonary hypertension (CTEPH): Diagnosis and Treatment Jun 27, 2019

Dr. Nicholas Smedira leads a panel of experts in the discussion of chronic thromboembolic pulmonary hypertension (CTEPH). Cardiac surgeon Dr. Michael Tong, pulmonologist Dr. Gustavo Heresi, interventional radiologist Dr. Ihab Haddadin, and vascular medicine specialist Dr. John Bartholomew provide insight into topics clinicians need to know to manage patients with CTEPH: diagnosis of pulmonary emboli vs. CTEPH, diagnostic imaging, management of acute vs. subacute emboli, patients at risk, surgery techniques vs. interventional approaches and postoperative care .

Nutrition, Supplements and Energy Drinks: Implications for Cardiac Care of the Athlete Jun 20, 2019

Kate Patton, Med, RD, CCSD, LD, Preventive Cardiology and athlete nutrition expert from our Sports Cardiology Center discusses the impact of supplements and energy drinks on cardiovascular health and athletic performance and foods that provide sports performance benefits.

Nutrition: Implications for Cardiac Care of the Athlete Jun 13, 2019

Cardiologist Dr. Tamanna Singh from our Sports Cardiology Center discusses diet and nutrition for optimal athletic performance, including nutritional sources, diet types and balancing nutrition for performance with nutrition for cardiovascular health as part of our Sports Cardiology Lecture Series.

Pericardial Cases: Advanced Constriction – Between a Rock and a Hard Place Jun 06, 2019

Dr. Allan Klein, Director of the Cleveland Clinic Pericardial Disease Center introduces pericarditis cases, a discussion of various types of pericarditis including presentation, imaging, pathology, treatment and considerations. Robert Montgomery, MD, Cardiovascular Medicine Fellow presents a case of advanced pericardial constriction. Dr. Paul Cremer moderates a panel including cardiac surgeon Shinya Unai, MD, cardiologists and imaging specialists Dr. Christine Jellis and Dr. Deborah Kwon, and pathologist Dr. Carmela Tan addressing surgical treatment, and advanced imaging.

Cardiac MRI: Clinician considerations when ordering a cardiac MRI May 30, 2019

Dr. Deborah Kwon Director of MRI in the Miller Family Heart & Vascular Institute at Cleveland Clinic answers questions about cardiac MRI: what is the best use? When should contrast be ordered? What is the latest research involving cardiac MRI? And - what clinicians should know about ordering MRI.

Pericardial Cases: Coming to Grips with Transient Constriction May 23, 2019

Dr. Allan Klein, Director of the Cleveland Clinic Pericardial Disease Center introduces pericarditis cases, a discussion of various types of pericarditis including presentation, imaging, pathology, treatment and considerations. Jay Ramchand, MD, Cardiovascular Medicine Fellow presents two cases of transient pericarditis. Dr. Paul Cremer moderates a panel including cardiac surgeon Shinya Unai, MD, cardiologists and imaging specialists Dr. Christine Jellis and Dr. Deborah Kwon, and pathologist Dr. Carmela Tan addressing surgical treatment, and advanced imaging.

Tafamidis treatment of transthyretin mediated amyloidosis (TTR) approved by FDA May 16, 2019

Mazen Hanna, MD, Co-Director of the Cleveland Clinic’s Amyloidosis Center talks about the FDA’s recent approval of the drug Tafamidis for the treatment of ATTR Amyloidosis (also known as Amyloid Transthyretin Amyloidosis), the research behind it, what this medication does, and what this means for patients.

Ethnic Differences in 10 Year Clinical Outcomes after Drug Eluting Stenting May 09, 2019

Stephen Ellis, MD, interventional cardiologist at Cleveland Clinic discusses the findings a study aimed at looking at long term outcomes of African American as compared to Caucasians following drug eluting stents (DES) presented at the 2019 American College of Cardiology Conference. Dr. Ellis describes the characteristics of the study group, interesting factors noted in late outcomes and strategies for improvements in the future.

Treatments for Carotid Artery Disease: Expert Panel Apr 25, 2019

Lee Kirksey, MD, vascular surgeon and Vice Chairman of Vascular Surgery, leads a discussion of treatment options for carotid artery disease with Sean Lyden, MD, Chairman of Vascular Surgery, and Christopher Smolock, MD, including results of randomized trials, approaches and timing for symptomatic carotid artery disease, outcomes and stroke risk following endarterectomy, approaches for asymptomatic patients with carotid stenosis, identifying high risk patients and the role of carotid stenting and medical management.

Echo Lab: Managing Quality, Productivity, Efficiency and Innovation Apr 18, 2019

Richard Grimm, DO, Director of the Echocardiography Laboratory, and Helga Lombardo, RDCS, FASE Supervisor, Echocardiography Lab, discuss many aspects of running a successful high volume echo lab.

Thoracic aorta disease in an asymptomatic primary prevention population Apr 11, 2019

Dr. Milind Desai, Medical Director of the Aorta Center, discusses a recently published paper looking at a series of asymptomatic middle aged males who underwent chest computed tomographyalong with coronary artery calcium scoring as part of a comprehensive primary prevention evaluation. About 16% had a dilated aortic root when indexed to height. Dr. Desai discusses the implications of these findings. Study can be reviewed in Circulation. 2018;139:557–558

ACC 2019 Highlights: TAVR, Electrophysiology, Anti-thrombotic Therapies Apr 04, 2019

A. Michael Lincoff, MD, Director of the Cleveland Clinic Coordinating Center for Clinical Research (C5Research), reviews the results from clinical trials presented at the 2019 American College of Cardiology Conference focusing on three major practice areas: 1) the use of transcatheter aortic valves (TAVR) in low risk patients (PARTNER 3, Evolut Low); 2) electrophysiology studies (Apple Heart, WRAP-IT) ; and 3) anti-thrombotic therapies in patients with atrial fibrillation, acute coronary syndrome or percutaneous intervention (AUGUSTUS, GLASSY). Dr. Lincoff summarizes the studies’ design and results, and provides insight into the potential impact on future care of patients based on these outcomes.

A data-zone scoring system to assess the generalizability of clinical trial results Mar 28, 2019

Luke Laffin, MD, cardiologist in the Section of Preventive Cardiology at Cleveland Clinic discusses his recently published paper with Stephanie Besser, MSA, MSPA, and Francis Alenghat, MD, PhD, from the University of Chicago which dove into the results of the SPRINT and ACCORD-BP trials to answer the question if trial results looking at a specific population of patients can apply to specific patients in clinic. The team developed a tool to answer this question.

Advances in hospital-based monitoring, analysis and responsiveness Mar 21, 2019

Steven Nissen, MD talks with Daniel Cantillon, MD, staff electrophysiologist and Medical Director for Cleveland Clinic’s Central Monitoring Unit about advanced approaches to telemetry monitoring for hospitalized patients. Dr. Cantillon leads a large central monitoring unit with sophisticated technology and risk stratification tools, triage algorithms and protocols and a well-trained staff. Dr. Cantillon and Dr. Nissen discuss the factors measured, what goes into the algorithms and how this type of technology can prevent emergency events – or allow for treatment before an emergency event occurs; as well as hopes for future technology and research.

STEMI Outcomes in High Risk Populations Mar 14, 2019

Dr. Venu Menon, Director of the Cardiac Intensive Care Unit and the Cardiovascular Fellowship Program talks with Dr. Anirudh Kumar, a second year cardiovascular fellow about his recent research related to two high risk populations of STEMI patients, those with cardiogenic shock and those who present with cardiac arrest who underwent PCI. The findings were shared related to short and long-term outcomes in these two patient populations. In addition, he describes how and if new STEMI protocols had an impact on these high risk patients.

Tall Rounds: Treatment of Bicuspid Aortic Valve Disease Mar 05, 2019

Eric Roselli, MD, Director of the Aorta Center at Cleveland Clinic leads the discussion on treatment of bicuspid aortic valve (BAV) disease. Joanna Ghobrial, MD discusses family screening; Leonardo Rodriguez, MD reviews clinical presentation; Milind Desai, M D discusses imaging; Douglas Johnston, MD covers valve choice in the young patient; Amar Krishnaswamy, MD & Samir Kapadia, MD covers patient candidates for TAVR and valve-in-valve; and finally Vidyasagar Kalahasti, MD discusses connective tissue disorders in bicuspid aortic valve disease. After listening, join us for the Tall Rounds® presentation on Bicuspid Aortic Valve Disease.

Long Term Outcomes after Aortic Valve Surgery in Patients with Aortic Regurgitation Feb 28, 2019

Cleveland Clinic cardiologist Dr. Milind Desai discusses a paper published in JACC Imaging studying 865 patients who underwent aortic valve surgery with severe aortic regurgitation. Baseline ejection fraction and LV strain were studied pre-procedure and post procedure to look at the impact of these values and overall mortality. Dr. Desai discusses the findings of the study and implications for future evaluation of patients with aortic regurgitation. The study can be reviewed in JACC Imaging.

Characteristics and Long Term Outcomes in Adults with Marfan Syndrome and Ascending Aorta Surgery Feb 21, 2019

Dr. Lars Svensson, Chairman of the Sydell and Arnold Miller Heart and Vascular Institute discusses a recently published paper with Dr. Milind Desai, Medical Director of the Aorta Center, looking at a series of 491 Marfan Syndrome (MFS) patients who presented for both emergent and/or prophylactic aorta surgery. Dr. Svensson provides a review of the MFS guidelines regarding when to operate. Dr. Desai explains multi-modality imaging including echo, MRI and CT scan when determining timing for surgery. The findings of the study are reviewed as well as implications for future care of patients with MFS. Read the study in the Journal of the American College of Cardiology and learn more about Marfan syndrome at the Marfan Foundation.

Heart Failure Awareness Feb 14, 2019

In honor of Heart Failure Awareness Week, Steven Nissen, MD, Chairman of the Robert and Suzanne Tomsich Department of Cardiovascular Medicine at Cleveland Clinic talks with Randall Starling, MD, MPH, President of the Heart Failure Society of America (HFSA) and Jerry Estep, MD, Section Head of Heart Failure at Cleveland Clinic about what we need to know about heart failure – whether a patient or provider; including the extent that heart failure affects us, treatment options – from medications – to the newest devices and transplant, and differences in causes and/or presentation based on gender and race.

Heart Failure Strategies: What’s new? Feb 12, 2019

Dr. Steven Nissen discusses talks with Jerry Estep, MD, Section Head, Heart Failure and Transplantation and Edward Soltesz, MD, Surgical Director of the Kaufman Center for Heart Failure and Recovery about innovations in heart failure surgery, including changes in LVAD therapy and heart transplant making an impact on patient outcomes, when patients should be referred for advanced heart failure therapy, LVAD back-up strategies for traditional cardiac surgery, the newest medications and when to prescribe, and the new technologies for pulmonary pressure monitoring.

Business Management in the Cardiac Cath Laboratory - CC and HBS Feb 07, 2019

Dr. Steven Nissen discusses talks with Harvard Business School Professor Michael Tushman, and Cleveland Clinic cardiologists Dr. Samir Kapadia, Section Head, Interventional Cardiology, and Dr. Grant Reed, authors of a recently published paper focused on operational efficiency in the cath lab. They provide guidance on how to deliver high quality care in a cost effective manner.

Art of picking the right diagnostic imaging for the right patient Jan 31, 2019

Steven Nissen, MD discusses with Christine Jellis, MD, PhD the wide array of multi-modality imaging including the various types nuclear, echo, CT and MRI testing; the advantages and best use cases of each and how to manage special populations.

Tools for improving clinical practice Jan 24, 2019

Dr. Steven Nissen discusses clinical effectiveness with Dr. Umesh Khot, Vice Chairman and director of the Center for Healthcare Delivery Innovation How do the factors of Quality, Operations, and Reimbursement work together to improve effectiveness and efficiency? Dr. Khot provides an example of his work with STEMI patients and how standardizing care improved door to balloon time as well as decreased patient care variability. Other examples are provided. This process has also provided opportunities for research and publications.

REGROUP: Is Endoscopic Vein Harvesting Safe? Jan 17, 2019

Dr. Faisal Bakaeen, Director of Cleveland Clinic's Coronary Artery Bypass Surgery Center discusses the findings of the REGROUP trial, which looked at and the safety and efficacy of using saphenous vein grafts harvested endoscopically versus those harvested via open techniques. He provides an explanation of the findings, noting no significant difference in rates of major adverse cardiac events between the two harvesting methods.

Left Atrial Appendage Closure: Preventing Strokes in Patients with Atrial Fibrillation Jan 10, 2019

Oussama Wazni, MD, Section Head, Cardiac Electrophysiology and Pacing and electrophysiologist Walid Saliba MD discuss atrial fibrillation stroke prevention, and the role of left atrial appendage occlusion: outcomes noted at Cleveland Clinic, what to do in patients that are unable to take Coumadin due to risk of bleeding, FDA indications, new technology available and the role of LAA occlusion in light of the newer anticoagulants.

Statin Intolerance: How to manage it in clinical practice Jan 03, 2019

Dr. Leslie Cho, Section Head, Preventive Cardiology and Rehabilitation and Director of Women’s Cardiovascular Center discusses tips for health care providers in treating statin intolerance. She covers common issues such as symptom management, medication choices, titration of meds, monitoring patients on statins, and the role of PCSK9 medications.

Hypertrophic Cardiomyopathy Dec 27, 2018

Dr. Steven Nissen, Chairman of the Robert and Suzanne Tomsich Department of Cardiovascular Medicine at Cleveland Clinic discusses hypertrophic cardiomyopathy (HCM) with experts: cardiologist Milind Desai, MD and cardiovascular surgeon, Nicholas Smedira, MD . Topics include diagnostic findings, the nuances of surgical approach, determining the appropriate treatment for the best outcomes including symptom relief and decreased incidence of cardiac death, and genetic screening.

Transcatheter Mitral Valve Repair in Patients with Heart Failure Dec 20, 2018

After the results of the COAPT trial were released, Dr. Kapadia, joined a panel of experts in imaging Dr. Griffin, heart failure Dr. Starling, heart surgery Dr. Mick, and structural intervention Dr. Krishnaswamy to discuss best practices in the treatment of functional mitral regurgitation in heart failure patients. Read more about key findings of the COAPT trial.

What you should know about cardiac rehabilitation Dec 13, 2018

Dr. Erik Van Iterson, Director of Cardiac Rehabilitation at Cleveland Clinic describes the benefits of cardiac rehabilitation for various patient populations, current enrollment statistics, factors that play into enrollment, tips for health care providers, what is included in cardiac rehab and new trends in cardiac rehabilitation programming.

Arterial Revascularization Trial (ART): What does it mean? Dec 06, 2018

Dr. Faisal Bakaeen, Director of Cleveland Clinic's Coronary Artery Bypass Surgery Center discusses the findings of the ART trial. He provides an explanation of the findings and encourages tailoring the surgery to the patient. Use of multi-arterial coronary artery bypass grafts for the right patient can provide the best long term outcomes.

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy Nov 29, 2018

Dr. Mazen Hanna describes the findings of ATTR-ACT, a study aimed at the treatment of transthyretin (TTR) amyloid cardiomyopathy with the medication tafamadis. Those who were treated with the medication had reduced mortality, hospitalizations, and better functional capacity and quality of life. This is an exciting new breakthrough for patients with TTR amyloidosis.

AHA 2018: Highlights with Dr. Steven Nissen Nov 22, 2018

Steven Nissen, MD, Chairman of the Robert and Suzanne Tomsich Department of Cardiovascular Medicine at Cleveland Clinic discusses several highlights from the 2018 AHA meeting: a summary of the newly released 2018 Management of Blood Cholesterol Guidelines; the outcomes of the VITAL trial which studied vitamin D and Omega 3’s impact on primary prevention of CV or cancer events; REDUCE-IT, a trial looking at the use of EPAs in the prevention of heart disease; and last, the results of a phase II, placebo-controlled study directed at patients with high levels of Lp(a), treated with a new drug.

Pericardial Cases: Surgical Management of Calcific Pericarditis Nov 15, 2018

Grant Henderson, MD, Cardiovascular Medicine Fellow presents a case if woman with constrictive calcific pericarditis including review of symptoms, imaging and considerations. Following a presentation of the pathology by Dr. Carmela Tan, Dr. Allan Klein, Director of the Cleveland Clinic Pericardial Disease Center leads a discussion and with cardiac surgeon Dr. Douglas Johnston and Dr. Deborah Kwon, addressing surgical treatment, and advanced imaging.

Pericardial Cases: Does Pericarditis Ever Get Better? Nov 08, 2018

Nikolaos Spilias, MD, Cardiovascular Medicine Fellow presents two cases of recurrent pericarditis, including presentation, imaging, treatment and considerations. Dr. Allan Klein, Director of the Cleveland Clinic Pericardial Disease Center leads a discussion and with cardiac surgeon Dr. Douglas Johnston and Dr. Deborah Kwon, addressing surgical treatment, and advanced imaging.

Pericarditis: The Challenges of Therapy Nov 01, 2018

Dr. Steven Nissen discusses the challenges of treating patients with pericarditis with Dr. Allan Klein, Director of the Cleveland Clinic Pericardial Disease Center – including medication management, monitoring with inflammatory markers and advanced therapies.

Care of Patients with Aortic Disease Oct 25, 2018

Dr. Steven Nissen, Dr. Sagar Kalahasti, Director of the Marfan & Connective Tissue Clinic and Dr. Eric Roselli, Director of the Aorta Center discuss the clinical care of patients with aortic disease (aneurysm and dissection), addressing testing, genetic evaluation, monitoring, when to operate, types of surgeries available, surgical outcomes and a life-long approach to treatment.

Detection of coronary inflammation using CT and cardiovascular risk prediction (the CRISP CT study) Oct 18, 2018

Dr. Milind Desai describes the findings of a paper showing that a novel biomarker found through CTA: the perivascular fat attenuation index (FAI), measures coronary inflammation, and enhances cardiac risk/mortality prediction.

Hypertension: What Clinicians Need to Know Oct 11, 2018

Dr. Luke Laffin, staff cardiologist in Preventive Cardiology and Clinical Specialist in Hypertension at Cleveland Clinic answers questions about hypertension management. He provides 5 main points clinicians need to know about fitting the hypertension guidelines into their daily practice and discusses tips for medication management, use of self-blood pressure monitoring and the role of lifestyle changes.

ESC 2018 Highlights of Late Breaking Trials Oct 04, 2018

Dr. Steve Nissen, Chairman of Cardiovascular Medicine at Cleveland Clinic shares what you need to know from five impactful trials: ATTR, ARRIVE, ASCEND, AIMS and MITRA, presented at the European Society of Cardiology Congress in Munich.

Catheter Ablation vs Antiarrhythmic Drug Therapy in Atrial Fibrillation: CABANA Sep 27, 2018

Oussama Wazni, MD, Section Head, Cardiac Electrophysiology and Pacing and Bruce Lindsay MD, past Section Head and past president of Heart Rhythm Society discusses the challenges and findings from the CABANA trial and its implications on future clinical practice, when to offer ablation vs. medical management.

Research: Putting Ideas into Action Sep 18, 2018

Dr. Steven Nissen is joined by interventional cardiologist Michael Lincoff, MD, Director of the Center for Clinical Research and Cleveland Clinic’s C5Research academic research organization, to share advice for physicians who want to get involved in research. They cover getting started, obtaining funding, following regulatory standards and making your research efforts a success.

Multidisciplinary Master Class in Endocarditis & Other Cardiovascular Infections: The Opioid Crisis Sep 06, 2018

Lars Svensson, MD, PhD, Chairman of the Miller Family Heart & Vascular Institute, leads an informative and lively panel discussion about the opioid crisis with clinical experts in infectious disease, cardiology, cardiovascular surgery, bioethics and chemical dependency, as well as U.S. Attorney Justin Herdman.

Digital Health: The Joys and Challenges of New Technology in Clinical Practice Sep 06, 2018

Dr. Steven Nissen discusses the use of digital devices in clinical care and research as well as the benefits and caveats of managing devices with electrophysiologist Khaldoun Tarakji, MD, MPH, Director of the Heart & Vascular Institute’s Center for Digital Health Technologies.

Our TOPPODCAST Picks

Follow Us

Stay Connected

Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals

Related Podcasts

Links

Stay Connected